β-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury

Journal of the American Society of Nephrology

Volumn 25, Issue 3, 2014, Pages 523-533

  Buelli, Simona ^a   Rosanò, Laura ^b   Gagliardini, Elena ^a   Corna, Daniela ^a   Longaretti, Lorena ^a   Pezzotta, Anna ^a   Perico, Luca ^a   Conti, Sara ^a   Rizzo, Paola ^a   Novelli, Rubina ^a   Morigi, Marina ^a   Zoja, Carlamaria ^a   Remuzzi, Giuseppe ^a,c   Bagnato, Anna ^b   Benigni, Ariela ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^c Azienda Ospedaliera Papa Giovanni XXIII   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BETA ARRESTIN 1; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE; SITAXSENTAN; SYNAPTOPODIN; TRANSCRIPTION FACTOR SNAIL;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL LOSS; CELL MIGRATION; CELL MOTILITY; COMPLEX FORMATION; CONTROLLED STUDY; GENE SILENCING; HYPERPLASIA; IN VITRO STUDY; KIDNEY INJURY; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSCRIPTION INITIATION;

ANIMALS; ARRESTINS; BETA CATENIN; CELL MOVEMENT; DISEASE MODELS, ANIMAL; DOXORUBICIN; ENDOTHELIN-1; FEMALE; GLOMERULONEPHRITIS; HUMANS; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; PODOCYTES; RECEPTOR, ENDOTHELIN A; RECEPTOR, EPIDERMAL GROWTH FACTOR; SRC-FAMILY KINASES; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 84896867400     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013040362     Document Type: Article

References (37)

1. Polyak K, Weinberg RA: Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273, 2009
2. Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celià-Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua Y, Wei Y, Hu G, Garcia BA, Ragoussis J, Amadori D, Harris AL, Kang Y: Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med 17: 1101-1108, 2011
3. Liu Y: New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21: 212-222, 2010
4. Li Y, Kang YS, Dai C, Kiss LP, Wen X, Liu Y: Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria. Am J Pathol 172: 299-308, 2008 (Pubitemid 351282018)
5. Benigni A, Morigi M, Rizzo P, Gagliardini E, Rota C, Abbate M, Ghezzi S, Remuzzi A, Remuzzi G: Inhibiting angiotensin-converting enzyme promotes renal repair by limiting progenitor cell proliferation and restoring the glomerular architecture. Am J Pathol 179: 628-638, 2011
6. Smeets B, Angelotti ML, Rizzo P, Dijkman H, Lazzeri E, Mooren F, Ballerini L, Parente E, Sagrinati C, Mazzinghi B, Ronconi E, Becherucci F, Benigni A, Steenbergen E, Lasagni L, Remuzzi G, Wetzels J, Romagnani P: Renal progenitor cells contribute to hyperplastic lesions of podocytopathies and crescentic glomerulonephritis. J Am Soc Nephrol 20: 2593-2603, 2009
7. Rosanò L, Spinella F, Di Castro V, Nicotra MR, Dedhar S, de Herreros AG, Natali PG, Bagnato A: Endothelin-1 promotes epithelial-to- mesenchymal transition in human ovarian cancer cells. Cancer Res 65: 11649-11657, 2005 (Pubitemid 41821725)
8. Rosanò L, Spinella F, Di Castro V, Dedhar S, Nicotra MR, Natali PG, Bagnato A: Integrin-linked kinase functions as a downstream mediator of endothelin-1 to promote invasive behavior in ovarian carcinoma. Mol Cancer Ther 5: 833-842, 2006 (Pubitemid 43724582)
9. Rosanò L, Cianfrocca R, Masi S, Spinella F, Di Castro V, Biroccio A, Salvati E, Nicotra MR, Natali PG, Bagnato A: Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis. Proc Natl Acad Sci U S A 106: 2806-2811, 2009
10. Barton M: Reversal of proteinuric renal disease and the emerging role of endothelin. Nat Clin Pract Nephrol 4: 490-501, 2008
11. Morigi M, Buelli S, Angioletti S, Zanchi C, Longaretti L, Zoja C, Galbusera M, Gastoldi S, Mundel P, Remuzzi G, Benigni A: In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: Implication for permselective dysfunction of chronic nephropathies. Am J Pathol 166: 1309-1320, 2005 (Pubitemid 40586503)
12. Fligny C, Barton M, Tharaux PL: Endothelin and podocyte injury in chronic kidney disease. Contrib Nephrol 172: 120-138, 2011
13. Gagliardini E, Corna D, Zoja C, Sangalli F, Carrara F, Rossi M, Conti S, Rottoli D, Longaretti L, Remuzzi A, Remuzzi G, Benigni A: Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes. Am J Physiol Renal Physiol 297: F1448-F1456, 2009
14. Zoja C, Garcia PB, Rota C, Conti S, Gagliardini E, Corna D, Zanchi C, Bigini P, Benigni A, Remuzzi G, Morigi M: Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy. Am J Physiol Renal Physiol 303: F1370-F1381, 2012
15. Piedra J, Martinez D, Castano J, Miravet S, Dunach M, de Herreros AG: Regulation of beta-catenin structure and activity by tyrosine phosphorylation. J Biol Chem 276: 20436-20443, 2001
16. Brembeck FH, Rosário M, Birchmeier W: Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 16: 51-59, 2006 (Pubitemid 43089612)
17. Lilien J, Balsamo J: The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr Opin Cell Biol 17: 459-465, 2005 (Pubitemid 41267159)
18. Thorner PS, Ho M, Eremina V, Sado Y, Quaggin S: Podocytes contribute to the formation of glomerular crescents. J Am Soc Nephrol 19: 495-502, 2008 (Pubitemid 351355393)
19. Shenoy SK, Lefkowitz RJ: β-Arrestin-mediated receptor trafficking and signal transduction. Trends Pharmacol Sci 32: 521-533, 2011
20. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK: Beta-arrestins and cell signaling. Annu Rev Physiol 69: 483-510, 2007
21. Buchanan FG, Gorden DL, Matta P, Shi Q, Matrisian LM, DuBois RN: Role of beta-arrestin 1 in the metastatic progression of colorectal cancer. Proc Natl Acad Sci U S A 103: 1492-1497, 2006 (Pubitemid 43191193)
22. Morigi M, Buelli S, Zanchi C, Longaretti L, Macconi D, Benigni A, Moioli D, Remuzzi G, Zoja C: Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling. Am J Pathol 169: 1965-1975, 2006 (Pubitemid 351181958)
23. Imamura T, Huang J, Dalle S, Ugi S, Usui I, Luttrell LM, Miller WE, Lefkowitz RJ, Olefsky JM: beta-Arrestin-mediated recruitment of the Src family kinase Yesmediates endothelin-1-stimulated glucose transport. J Biol Chem 276: 43663-43667, 2001
24. Cianfrocca R, Tocci P, Spinella F, Di Castro V, Bagnato A, Rosanò L: The endothelin A receptor and epidermal growth factor receptor signaling converge on β-catenin to promote ovarian cancer metastasis. Life Sci 91: 550-556, 2012
25. Rosanò L, Cianfrocca R, Tocci P, Spinella F, Di Castro V, Spadaro F, Salvati E, Biroccio AM, Natali PG, Bagnato A: β-arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced β-catenin signaling [published online ahead of print December 3, 2012]. Oncogene doi:10.1038/onc.2012.527
26. Bertani T, Poggi A, Pozzoni R, Delaini F, Sacchi G, Thoua Y, Mecca G, Remuzzi G, Donati MB: Adriamycin-induced nephrotic syndrome in rats: Sequence of pathologic events. Lab Invest 46: 16-23, 1982 (Pubitemid 12167012)
27. Ji Z, Huang C, Liang C, Chen B, Chen S, Sun W: Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis. Cell Mol Immunol 2: 150-154, 2005
28. Dhaun N, MacIntyre IM, Kerr D, Melville V, Johnston NR, Haughie S, Goddard J, Webb DJ: Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease. Hypertension 57: 772-779, 2011
29. Wenzel RR, Littke T, Kuranoff S, Jürgens C, Bruck H, Ritz E, Philipp T, Mitchell A; SPP301 (Avosentan) Endothelin Antagonist Evaluation in Diabetic Nephropathy Study Investigators: Avosentan reduces albumin excretion in diabetics with macroalbuminuria. J Am Soc Nephrol 20: 655-664, 2009
30. Heikkilä E, Juhila J, Lassila M, Messing M, Perälä N, Lehtonen E, Lehtonen S, Sjef Verbeek J, Holthofer H: beta-Catenin mediates adriamycin-induced albuminuria and podocyte injury in adult mouse kidneys. Nephrol Dial Transplant 25: 2437-2446, 2010
31. Dai C, Stolz DB, Kiss LP, Monga SP, Holzman LB, Liu Y: Wnt/beta-catenin signaling promotes podocyte dysfunction and albuminuria. J Am Soc Nephrol 20: 1997-2008, 2009
32. Mele C, Iatropoulos P, Donadelli R, Calabria A, Maranta R, Cassis P, Buelli S, Tomasoni S, Piras R, Krendel M, Bettoni S, Morigi M, Delledonne M, Pecoraro C, Abbate I, Capobianchi MR, Hildebrandt F, Otto E, Schaefer F, Macciardi F, Ozaltin F, Emre S, Ibsirlioglu T, Benigni A, Remuzzi G, Noris M; PodoNet Consortium: MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N Engl J Med 365: 295-306, 2011
33. Lal A, Haynes SR, Gorospe M: Clean Western blot signals from immunoprecipitated samples. Mol Cell Probes 19: 385-388, 2005 (Pubitemid 41586134)
34. Wang Y, Wang YP, Tay YC, Harris DC: Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int 58: 1797-1804, 2000
35. Weibel ER: Stereological Methods: Practical Methods for Morpometry, New York, Academic, 1979
36. Macconi D, Bonomelli M, Benigni A, Plati T, Sangalli F, Longaretti L, Conti S, Kawachi H, Hill P, Remuzzi G, Remuzzi A: Pathophysiologic implications of reduced podocyte number in a ratmodel of progressive glomerular injury. Am J Pathol 168: 42-54, 2006 (Pubitemid 43062558)
37. Gagliardini E, Conti S, Benigni A, Remuzzi G, Remuzzi A: Imaging of the porous ultrastructure of the glomerular epithelial filtration slit. J Am Soc Nephrol 21: 2081-2089, 2010